Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - Eli Lilly
1/7/26 at 9:21pm
Organization
Lilly.com
35 words
0
Comments
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
Pharmaceuticals & Biotech
Business & Industrial
Company News
You are the first to view
https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-ventyx-biosciences-advance-oral-therapies
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...